Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Linda Joanne Van Marter, M.D.

TitleAssociate Professor of Pediatrics
InstitutionBrigham and Women's Hospital
DepartmentPediatrics
AddressChildrens Hospital
Newborn Medicine, Hunnewell 438
300 Longwood Ave
Boston MA 02115
Phone617/355-6027
Fax617/738-1044

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. McElrath T, Allred E, Van Marter L, Fichorova R, Leviton A. Perinatal systemic inflammatory responses of growth-restricted preterm newborns. Acta Paediatr. 2013 Oct; 102(10):e439-42.
    View in: PubMed
  2. Levesque BM, Kalish LA, Winston AB, Parad RB, Hernandez-Diaz S, Phillips M, Zolit A, Morey J, Gupta M, Mammoto A, Ingber DE, Van Marter LJ. Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology. 2013; 104(1):56-64.
    View in: PubMed
  3. Van Marter LJ, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA. Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn. Pediatrics. 2013 Jan; 131(1):79-87.
    View in: PubMed
  4. Bose CL, Laughon MM, Allred EN, O'Shea TM, Van Marter LJ, Ehrenkranz RA, Fichorova RN, Leviton A. Systemic inflammation associated with mechanical ventilation among extremely preterm infants. Cytokine. 2013 Jan; 61(1):315-22.
    View in: PubMed
  5. Nathe KE, Mancuso CJ, Parad R, Van Marter LJ, Martin CR, Stoler-Barak L, Philbin VJ, Phillips MF, Palmer CD, Levy O. Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation. Pediatr Res. 2012 Aug; 72(2):203-11.
    View in: PubMed
  6. O'Reilly D, Navakatikyan MA, Filip M, Greene D, Van Marter LJ. Peak-to-peak amplitude in neonatal brain monitoring of premature infants. Clin Neurophysiol. 2012 Nov; 123(11):2139-53.
    View in: PubMed
  7. Laughon M, Bose C, Allred EN, O'shea TM, Ehrenkranz RA, VAN Marter LJ, Leviton A. Patterns of blood protein concentrations of ELGANs classified by three patterns of respiratory disease in the first 2 postnatal weeks. Pediatr Res. 2011 Sep; 70(3):292-6.
    View in: PubMed
  8. Gregory KE, Deforge CE, Natale KM, Phillips M, Van Marter LJ. Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation. Adv Neonatal Care. 2011 Jun; 11(3):155-64; quiz 165-6.
    View in: PubMed
  9. Bose C, Laughon M, Allred EN, Van Marter LJ, O'Shea TM, Ehrenkranz RA, Fichorova R, Leviton A. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Pediatr Res. 2011 Apr; 69(4):347-53.
    View in: PubMed
  10. Bhatt DR, White R, Martin G, Van Marter LJ, Finer N, Goldsmith JP, Ramos C, Kukreja S, Ramanathan R. Transitional hypothermia in preterm newborns. Adv Neonatal Care. 2010 Oct; 10(5 Suppl):S15-7.
    View in: PubMed
  11. Van Marter LJ, Kuban KC, Allred E, Bose C, Dammann O, O'Shea M, Laughon M, Ehrenkranz RA, Schreiber MD, Karna P, Leviton A. Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch Dis Child Fetal Neonatal Ed. 2011 Jan; 96(1):F20-9.
    View in: PubMed
  12. Laughon M, Bose C, Allred EN, O'Shea TM, Ehrenkranz RA, Van Marter LJ, Leviton A. Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2011 Mar; 96(2):F114-20.
    View in: PubMed
  13. Wintermark P, Boyd T, Parast MM, Van Marter LJ, Warfield SK, Robertson RL, Ringer SA. Fetal placental thrombosis and neonatal implications. Am J Perinatol. 2010 Mar; 27(3):251-6.
    View in: PubMed
  14. Van Marter LJ. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med. 2009 Dec; 14(6):358-66.
    View in: PubMed
  15. Bose C, Van Marter LJ, Laughon M, O'Shea TM, Allred EN, Karna P, Ehrenkranz RA, Boggess K, Leviton A. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics. 2009 Sep; 124(3):e450-8.
    View in: PubMed
  16. Nathe KE, Parad R, Van Marter LJ, Lund CA, Suter EE, Hernandez-diaz S, Boush EB, Ikonomu E, Gallington L, Morey JA, Zeman AM, Mcnamara M, Levy O. Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates. Pediatr Res. 2009 Aug; 66(2):191-6.
    View in: PubMed
  17. Laughon M, O'Shea MT, Allred EN, Bose C, Kuban K, Van Marter LJ, Ehrenkranz RA, Leviton A. Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation. Pediatrics. 2009 Aug; 124(2):637-48.
    View in: PubMed
  18. Laughon M, Allred EN, Bose C, O'Shea TM, Van Marter LJ, Ehrenkranz RA, Leviton A. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics. 2009 Apr; 123(4):1124-31.
    View in: PubMed
  19. Bhatt DR, White R, Martin G, Van Marter LJ, Finer N, Goldsmith JP, Ramos C, Kukreja S, Ramanathan R. Transitional hypothermia in preterm newborns. J Perinatol. 2007 Dec; 27 Suppl 2:S45-7.
    View in: PubMed
  20. Hernández-Díaz S, Van Marter LJ, Werler MM, Louik C, Mitchell AA. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics. 2007 Aug; 120(2):e272-82.
    View in: PubMed
  21. Laughon M, Bose C, Allred E, O'Shea TM, Van Marter LJ, Bednarek F, Leviton A. Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week. Pediatrics. 2007 Feb; 119(2):273-80.
    View in: PubMed
  22. Cohen J, Van Marter LJ, Sun Y, Allred E, Leviton A, Kohane IS. Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia. Genome Biol. 2007; 8(10):R210.
    View in: PubMed
  23. Van Marter LJ. Progress in discovery and evaluation of treatments to prevent bronchopulmonary dysplasia. Biol Neonate. 2006; 89(4):303-12.
    View in: PubMed
  24. Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, Blackmon L, Jobe A. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics. 2006 Mar; 117(3 Pt 2):S52-6.
    View in: PubMed
  25. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006 Feb 9; 354(6):579-87.
    View in: PubMed
  26. Van Marter LJ. Strategies for preventing bronchopulmonary dysplasia. Curr Opin Pediatr. 2005 Apr; 17(2):174-80.
    View in: PubMed
  27. Martin CR, Van Marter LJ, Allred EN, Leviton A. Antenatal glucocorticoids increase early total thyroxine levels in premature infants. Biol Neonate. 2005; 87(4):273-80.
    View in: PubMed
  28. Raju TN, Ariagno RL, Higgins R, Van Marter LJ. Research in neonatology for the 21st century: executive summary of the National Institute of Child Health and Human Development-American Academy of Pediatrics workshop. Part I: academic issues. Pediatrics. 2005 Feb; 115(2):468-74.
    View in: PubMed
  29. Ariagno RL, Van Marter LJ, Higgins R, Raju TN. Neonatology research for the 21st century: executive summary of the National Institute of Child Health and Human Development-American Academy of Pediatrics workshop. Part II: training issues. Pediatrics. 2005 Feb; 115(2):475-9.
    View in: PubMed
  30. Dammann O, Allred EN, Van Marter LJ, Dammann CE, Leviton A. Bronchopulmonary dysplasia is not associated with ultrasound-defined cerebral white matter damage in preterm newborns. Pediatr Res. 2004 Feb; 55(2):319-25.
    View in: PubMed
  31. Billman GF, Hughes AB, Dudell GG, Waldman E, Adcock LM, Hall DM, Orsini EN, Koska AJ, Van Marter LJ, Finer NN, Kulhavy JC, Feld RD, Widness JA. Clinical performance of an in-line, ex vivo point-of-care monitor: a multicenter study. Clin Chem. 2002 Nov; 48(11):2030-43.
    View in: PubMed
  32. Cullen A, Van Marter LJ, Allred EN, Moore M, Parad RB, Sunday ME. Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2002 Apr 15; 165(8):1093-7.
    View in: PubMed
  33. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, Martin C. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr. 2002 Feb; 140(2):171-6.
    View in: PubMed
  34. Dammann O, Allred EN, Kuban KC, Van Marter LJ, Pagano M, Sanocka U, Leviton A. Systemic hypotension and white-matter damage in preterm infants. Dev Med Child Neurol. 2002 Feb; 44(2):82-90.
    View in: PubMed
  35. Stewart JE, Allred EN, Collins M, Abbott J, Leviton A, Paneth N, Reuss ML, Susser M, Hegyi T, Hiatt M, Sanocka U, Shahrivar F, Van Marter LJ, Banogan P, Genest D, Heller D, Shen-Schwarz S, Dammann O, Kuban KC, Pagano M. Risk of cranial ultrasound abnormalities in very-low-birth-weight infants conceived with assisted reproductive techniques. J Perinatol. 2002 Jan; 22(1):37-45.
    View in: PubMed
  36. Martin CR, Van Marter LJ, Allred EN, Leviton A. Growth-restricted premature infants are at increased risk for low thyroxine. Early Hum Dev. 2001 Sep; 64(2):119-28.
    View in: PubMed
  37. Dammann O, Allred EN, Kuban KC, van Marter LJ, Stewart JE, Pagano M, Leviton A. Hypocarbia during the first 24 postnatal hours and white matter echolucencies in newborns < or = 28 weeks gestation. Pediatr Res. 2001 Mar; 49(3):388-93.
    View in: PubMed
  38. Dammann O, Phillips TM, Allred EN, O'Shea TM, Paneth N, Van Marter LJ, Bose C, Ehrenkranz RA, Bednarek FJ, Naples M, Leviton A. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine. 2001 Feb 21; 13(4):234-9.
    View in: PubMed
  39. Van Marter LJ, Allred EN, Leviton A, Pagano M, Parad R, Moore M. Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr. 2001 Feb; 138(2):198-204.
    View in: PubMed
  40. Christou H, Van Marter LJ, Wessel DL, Allred EN, Kane JW, Thompson JE, Stark AR, Kourembanas S. Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med. 2000 Nov; 28(11):3722-7.
    View in: PubMed
  41. Berger TM, Allred EN, Van Marter LJ. Antecedents of clinically significant pulmonary hemorrhage among newborn infants. J Perinatol. 2000 Jul-Aug; 20(5):295-300.
    View in: PubMed
  42. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics. 2000 Jun; 105(6):1194-201.
    View in: PubMed
  43. Cataltepe S, van Marter LJ, Kozakewich H, Wessel DL, Lee PJ, Levy HL. Pulmonary hypertension associated with nonketotic hyperglycinaemia. J Inherit Metab Dis. 2000 Mar; 23(2):137-44.
    View in: PubMed
  44. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, Kuban K, Van Marter LJ, Pagano M, Hegyi T, Hiatt M, Sanocka U, Shahrivar F, Abiri M, Disalvo D, Doubilet P, Kairam R, Kazam E, Kirpekar M, Rosenfeld D, Schonfeld S, Share J, Collins M, Genest D, Shen-Schwarz S, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res. 1999 Nov; 46(5):566-75.
    View in: PubMed
  45. Leviton A, Dammann O, Allred EN, Kuban K, Pagano M, Van Marter L, Paneth N, Reuss ML, Susser M. Antenatal corticosteroids and cranial ultrasonographic abnormalities. Am J Obstet Gynecol. 1999 Oct; 181(4):1007-17.
    View in: PubMed
  46. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, Kuban K, Van Marter LJ, Pagano M. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr. 1999 Jun; 134(6):706-11.
    View in: PubMed
  47. Christou H, Magnani B, Morse DS, Allred EN, Van Marter LJ, Wessel DL, Kourembanas S. Inhaled nitric oxide does not affect adenosine 5'-diphosphate-dependent platelet activation in infants with persistent pulmonary hypertension of the newborn. Pediatrics. 1998 Dec; 102(6):1390-3.
    View in: PubMed
  48. Wessel DL, Adatia I, Van Marter LJ, Thompson JE, Kane JW, Stark AR, Kourembanas S. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics. 1997 Nov; 100(5):E7.
    View in: PubMed
  49. Leviton A, Paneth N, Susser M, Reuss ML, Allred EN, Kuban K, Sanocka U, Hegyi T, Hiatt M, Shahrivar F, Van Marter LJ. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. Pediatrics. 1997 Apr; 99(4):E2.
    View in: PubMed
  50. Christou H, Adatia I, Van Marter LJ, Kane JW, Thompson JE, Stark AR, Wessel DL, Kourembanas S. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr. 1997 Apr; 130(4):603-11.
    View in: PubMed
  51. Van Marter LJ, Leviton A, Allred EN, Pagano M, Sullivan KF, Cohen A, Epstein MF. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics. 1996 May; 97(5):658-63.
    View in: PubMed
  52. Bianchi DW, Van Marter LJ. An approach to ventilator-dependent neonates with arthrogryposis. Pediatrics. 1994 Nov; 94(5):682-6.
    View in: PubMed
  53. Leviton A, Kuban KC, Pagano M, Allred EN, Van Marter L. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics. 1993 Jun; 91(6):1083-8.
    View in: PubMed
  54. Van Marter LJ, Pagano M, Allred EN, Leviton A, Kuban KC. Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr. 1992 Jun; 120(6):938-46.
    View in: PubMed
  55. Shneider B, Cronin J, Van Marter L, Maller E, Truog R, Jacobson M, Kevy S. A prospective analysis of cholestasis in infants supported with extracorporeal membrane oxygenation. J Pediatr Gastroenterol Nutr. 1991 Oct; 13(3):285-9.
    View in: PubMed
  56. Van Marter LJ, Leviton A, Kuban KC, Pagano M, Allred EN. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics. 1990 Sep; 86(3):331-6.
    View in: PubMed
  57. Van Marter LJ, Leviton A, Allred EN, Pagano M, Kuban KC. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr. 1990 Jun; 116(6):942-9.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Van Marter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_